GARFIELD BEACH CVS LLC
Pharmacy · LOS ANGELES, CA
Organization Active NPI 1457392375
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,532 | 5,052 | $424,218 | $413,099 | $413,099 |
| 2023 | 1,956 | 9,093 | $424,362 | $411,796 | $411,796 |
| 2022 | 2,104 | 8,629 | $259,710 | $237,707 | $237,707 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 90480 | Admn sarscov2 vacc 1 dose | 1,388 | $40 | $40 |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | 1,363 | $151 | $151 |
| G0008 | Administration of influenza virus vaccine | 1,036 | $30 | $30 |
| 90662 | Influenza vaccine split virus, preservative free | 732 | $82 | $82 |
| 90653 | Influenza vaccine, inactivated | 181 | $82 | $82 |
| G0009 | Administration of pneumococcal vaccine | 102 | $31 | $31 |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 102 | $290 | $290 |
| 90673 | Influenza vaccine, trivalent derived from recombinant dna | 80 | $82 | $82 |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 26 | $76 | $76 |
| 91304 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage, for intramuscular use | 25 | $151 | $151 |
| 90661 | Influenza vaccine, trivalent derived from cell cultures | 12 | $36 | $36 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Pharmacy | 333600000X | ✓ | — | — |
| Durable Medical Equipment & Medical Supplies | 332B00000X | — | — | |
| Community/Retail Pharmacy | 3336C0003X | — | — |
Other Pharmacy providers in California
- NPI 1649791633
- NPI 1467102525
- NPI 1568892305
- NPI 1720418569
- NPI 1255761094
- NPI 1770913527
- NPI 1437806833
- NPI 1043356488
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.